Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Laharie
Gauthier Pellet

Showing results (1-10 of 210) with videos related to

Pageof 21
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2018
ReplyDavid Laharie, Gauthier Pellet
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2022
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative ColitisPauline Veyrard, Gauthier Pellet, David Laharie, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|January 29, 2022
Male gender is associated with informal caregiver burden in patients with chronic intestinal failure treated with home parenteral nutritionJean Castinel, Gauthier Pellet, David Laharie, et al.
Lancet (London, England)|May 22, 2017
Towards therapeutic choices in ulcerative colitisDavid Laharie
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2022
ReplyDavid Laharie
Digestive Diseases (Basel, Switzerland)|December 23, 2014
Previous cancer and/or lymphoma in patients with refractory IBD--pro: anti-TNF or immunosuppressive treatmentDavid Laharie
Alimentary Pharmacology & Therapeutics|February 13, 2024
Letter: Should ulcerative colitis be monitored more or less invasively?David Laharie
Alimentary Pharmacology & Therapeutics|February 18, 2021
Editorial: is enteral nutrition back in acute severe ulcerative colitis?David Laharie
Inflammatory Bowel Diseases|August 2, 2022
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral CentersPauline Rivière, Caitlyn Kanters, Gauthier Pellet, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: don't forget basic performance measures in the endoscopic assessment of ulcerative colitisDavid Laharie, Pauline Rivière
Pageof 21

Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 25, 2018
ReplyDavid Laharie, Gauthier Pellet
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 21, 2022
Efficacy of Induction Therapy With Calcineurin Inhibitors in Combination With Ustekinumab for Acute Severe Ulcerative ColitisPauline Veyrard, Gauthier Pellet, David Laharie, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|January 29, 2022
Male gender is associated with informal caregiver burden in patients with chronic intestinal failure treated with home parenteral nutritionJean Castinel, Gauthier Pellet, David Laharie, et al.
Lancet (London, England)|May 22, 2017
Towards therapeutic choices in ulcerative colitisDavid Laharie
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2022
ReplyDavid Laharie
Digestive Diseases (Basel, Switzerland)|December 23, 2014
Previous cancer and/or lymphoma in patients with refractory IBD--pro: anti-TNF or immunosuppressive treatmentDavid Laharie
Alimentary Pharmacology & Therapeutics|February 13, 2024
Letter: Should ulcerative colitis be monitored more or less invasively?David Laharie
Alimentary Pharmacology & Therapeutics|February 18, 2021
Editorial: is enteral nutrition back in acute severe ulcerative colitis?David Laharie
Inflammatory Bowel Diseases|August 2, 2022
Comparative Effectiveness of Ustekinumab and Anti-TNF Agent as First-Line Biological Therapy in Luminal Crohn's Disease: A Retrospective Study From 2 Referral CentersPauline Rivière, Caitlyn Kanters, Gauthier Pellet, et al.
Alimentary Pharmacology & Therapeutics|December 15, 2021
Editorial: don't forget basic performance measures in the endoscopic assessment of ulcerative colitisDavid Laharie, Pauline Rivière
Pageof 21